Switzerland 75% owned Portfolio

Marry Jane AG

Indoor cannabis cultivation at industrial scale.

17,000 m²
Indoor cultivation facility near Basel
18 t
Annual flower capacity, up to 22 t at full utilisation
Since 2020
Continuous CBD production track record
About

One of Europe’s largest indoor cannabis facilities, in Breitenbach.

Marry Jane AG operates one of Europe’s largest indoor cannabis cultivation facilities, located in Breitenbach, Switzerland. The site has been in continuous production since 2020 and supplies the Swiss and European premium CBD market.

The facility is licensed for CBD, medical THC and extraction. Capacity expansion of approximately three times the current footprint is feasible within the existing site.

Facility layout

Designed for vertical integration of every cultivation stage.

The Breitenbach footprint is structured around four cultivation stages and a continuous expansion zone. Each room category is sized for end-to-end yield throughput.

Marry Jane facility layout — Breitenbach (layout image pending)

Marry Jane is one of the few large-scale indoor cannabis facilities in Switzerland with this expansion optionality already in place. High-resolution layout image to be supplied by client.

Specifications

Built for industrial-scale indoor cultivation.

Total facility area
17,000 m²
Annual flower capacity
18 t today, up to 22 t at full utilisation
Cultivation method
Indoor, fully automated
Mother plant rooms
2 rooms · 1,186 m²
Propagation rooms
2 rooms · 203 m²
Early flower rooms
7 rooms · 1,136 m²
Flowering rooms
10 rooms · 680 m² each
Licences
CBD · Medical THC · Extraction
Location
Breitenbach, Switzerland (near Basel)
What this position delivers

Three structural advantages embedded in the asset.

01

Industrial scale

A fully automated facility with proprietary climate, irrigation and CO&sub2; control — sized for consistent, high-volume output.

02

Scarcity by planning law

Building a comparable facility in Switzerland is materially constrained by current planning rules — the asset cannot easily be replicated.

03

Optionality

A genetics library and existing licences allow the facility to address CBD, medical THC and the future Swiss recreational market without new construction.

A regulated industry deserves a regulated investor.

Essence Investment AG · Switzerland

Get in touch